Moneycontrol BureauIpca Laboratories' fourth quarter profit more than doubled to Rs 37.7 crore compared to Rs 16.5 crore in year-ago period, driven by strong operational performance and tax write-back of Rs 19 crore.
Revenue declined to Rs 624.6 crore in January-March quarter compared to Rs 630.6 crore in corresponding period of last fiscal.
Operating profit (EBITDA - earnings before interest, tax, depreciation and amortisation) shot up 72.2 percent to Rs 63.5 crore and margin expanded by 440 basis points to 10.2 percent in Q4.
At 13:28 hours IST, the scrip of Ipca Laboratories was quoting at Rs 451.00, up Rs 15.05, or 3.45 percent on BSE.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.